Chronic, low-level LPS in the bloodstream causing persistent low-grade systemic inflammation.
Metabolic endotoxemia is the chronic, low-grade elevation of bacterial lipopolysaccharide (LPS) in the bloodstream due to increased intestinal permeability. This persistent inflammation is associated with metabolic dysfunction and chronic disease.
Unlike acute endotoxemia from severe infections, metabolic endotoxemia develops gradually from repeated, small amounts of LPS crossing a compromised intestinal barrier. This persistent endotoxin exposure triggers continuous immune activation, increasing inflammatory markers like TNF-α and IL-6. Over time, this chronic inflammation contributes to insulin resistance, obesity, metabolic syndrome, and increased risk of cardiovascular disease. Metabolic endotoxemia is often associated with dysbiosis, high-fat/high-sugar diets, and conditions that increase intestinal permeability.
Perpetuates systemic inflammation and metabolic dysfunction through continuous immune activation.
Adopt an anti-inflammatory diet rich in fiber, polyphenols, and omega-3 fatty acids to reduce dysbiosis and barrier dysfunction. Test for elevated LPS levels and zonulin if experiencing metabolic issues. Consider prebiotic and probiotic interventions under professional guidance to restore microbiome balance and reduce inflammation.
Addressing metabolic endotoxemia through microbiome restoration and barrier repair is essential for preventing chronic metabolic diseases.
A question about Metabolic Endotoxemia? Ask our nutrition AI.
Ask a question